Reply to: "Interferon-free therapy of hepatitis C during wait list and post transplant risk of hepatocellular carcinoma recurrence".

Yang, Ju Dong; Leise, Michael D

Yang, Ju Dong; Leise, Michael D.

Afiliação

Yang JD; Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Leise MD; Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA. Electronic address: Leise.Michael@mayo.edu.

J Hepatol ; 67(6): 1357, 2017 12.

Article em En | MEDLINE | ID: mdl-28800877

Assuntos

Carcinoma Hepatocelular; Hepatite C; Neoplasias Hepáticas; Hepacivirus; Humanos; Recidiva Local de Neoplasia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite C / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google